Reference
1. McBride, H. M., Neuspiel, M. & Wasiak, S. Mitochondria: more than just a powerhouse.
Curr. Biol. 16, R551–60 (2006).
2. Pittis, A. A. & Gabaldón, T. Late acquisition of mitochondria by a host with chimaeric prokaryotic ancestry. Nature 531, 101–104 (2016).
3. Gaziev, A. I. & Shaĭkhaev, G. O. [Nuclear mitochondrial pseudogenes]. Mol. Biol. (Mosk.) 44, 405–417 (2010).
4. Wallace, D. C. Mitochondrial genetic medicine. Nat. Genet. 50, 1642–1649 (2018).
5. Bacman, S. R., Williams, S. L., Duan, D. & Moraes, C. T. Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease. Gene Ther 19, 1101–1106 (2011).
6. Bacman, S. R., Williams, S. L., Pinto, M., Peralta, S. & Moraes, C. T. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nature
Medicine 2013 19:9 19, 1111–1113 (2013).
7. Gammage, P. A., Rorbach, J., Vincent, A. I., Rebar, E. J. & Minczuk, M. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol Med 6, 458–466 (2014).
8. Man, P. Y. W., Turnbull, D. M. & Chinnery, P. F. Leber hereditary optic neuropathy.
Journal of Medical Genetics 39, 162–169 (2002).
9. Rahman, S. et al. Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Ann. Neurol. 39, 343–351 (1996).
10. Lake, N. J., Compton, A. G., Rahman, S. & Thorburn, D. R. Leigh syndrome: One disorder, more than 75 monogenic causes. Ann. Neurol. 79, 190–203 (2016).
11. Wallace, D. C. Why Do We Still Have a Maternally Inherited Mitochondrial DNA?
Insights from Evolutionary Medicine. Annual Review of Biochemistry 76, 781–821 (2007).
12. Schwartz, M. & Vissing, J. New patterns of inheritance in mitochondrial disease. Biochem.
Biophys. Res. Commun. 310, 247–251 (2003).
13. Tuppen, H. A. L., Blakely, E. L., Turnbull, D. M. & Taylor, R. W. Mitochondrial DNA mutations and human disease. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1797, 113–128 (2010).
14. Jenuth, J. P., Peterson, A. C. & Shoubridge, E. A. Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nat. Genet. 16, 93–95 (1997).
15. Alexeyev, M. F. et al. Selective elimination of mutant mitochondrial genomes as
therapeutic strategy for the treatment of NARP and MILS syndromes. Gene Ther 46, 428–
8 (2008).
16. Bacman, S. R., Williams, S. L., Garcia, S. & Moraes, C. T. Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease. Gene Ther 17, 713–720 (2010).
17. Reddy, P. et al. Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing. Cell 161, 459–469 (2015).
18. Van Houten, B., Hunter, S. E. & Meyer, J. N. Mitochondrial DNA damage induced autophagy, cell death, and disease. Front Biosci (Landmark Ed) 21, 42–54 (2016).
19. Patananan, A. N., Wu, T.-H., Chiou, P.-Y. & Teitell, M. A. Modifying the Mitochondrial
20. Tanaka, M. et al. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J. Biomed. Sci. 9, 534–541 (2002).
21. Bayona-Bafaluy, M. P., Blits, B., Battersby, B. J., Shoubridge, E. A. & Moraes, C. T.
Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proc. Natl. Acad. Sci. U.S.A. 102, 14392–14397 (2005).
22. Smith, J. et al. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res. 28, 3361–3369 (2000).
23. Hockemeyer, D. et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29, 731–734 (2011).
24. Sung, Y. H. et al. Knockout mice created by TALEN-mediated gene targeting. Nat.
Biotechnol. 31, 23–24 (2013).
25. Dutta, S., Madan, S. & Sundar, D. Exploiting the recognition code for elucidating the mechanism of zinc finger protein-DNA interactions. BMC Genomics 17, 1037 (2016).
26. Minczuk, M., Papworth, M. A., Miller, J. C., Murphy, M. P. & Klug, A. Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA. Nucleic Acids Res. 36, 3926–3938 (2008).
27. Hashimoto, M. et al. MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases. Mol. Ther. 23, 1592–1599 (2015).
28. Wright, A. V., Nuñez, J. K. & Doudna, J. A. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering. Cell 164, 29–44 (2016).
29. Jinek, M. et al. A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science 337, 816–821 (2012).
30. Jo, A. et al. Research Article Efficient Mitochondrial Genome Editing by CRISPR/Cas9.
BioMed Research International 1–10 (2015). doi:10.1155/2015/305716
31. Gammage, P. A., Moraes, C. T. & Minczuk, M. Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized. Trends Genet. (2017).
doi:10.1016/j.tig.2017.11.001
32. Loutre, R., Heckel, A.-M., Smirnova, A., Entelis, N. & Tarassov, I. Can Mitochondrial DNA be CRISPRized: Pro and Contra. IUBMB Life 85, 133 (2018).
33. Bian, W.-P. et al. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System. ACS Synth Biol 8, 621–632 (2019).
34. Schumann, K. et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc. Natl. Acad. Sci. U.S.A. 112, 10437–10442 (2015).
35. Zhou, J., Liu, L. & Chen, J. Mitochondrial DNA heteroplasmy in Candida glabrata after mitochondrial transformation. Eukaryotic Cell 9, 806–814 (2010).
36. Mileshina, D., Koulintchenko, M., Konstantinov, Y. & Dietrich, A. Transfection of plant mitochondria and in organello gene integration. Nucleic Acids Res. 39, e115–e115 (2011).
37. D'Aurelio, M. et al. Heterologous mitochondrial DNA recombination in human cells. Hum.
Mol. Genet. 13, 3171–3179 (2004).
38. Gilkerson, R. W., Schon, E. A., Hernandez, E. & Davidson, M. M. Mitochondrial nucleoids maintain genetic autonomy but allow for functional complementation. J. Cell Biol. 181, 1117–1128 (2008).
39. Bacman, S. R., Williams, S. L. & Moraes, C. T. Intra- and inter-molecular recombination of mitochondrial DNA after in vivo induction of multiple double-strand breaks. Nucleic Acids Res. 37, 4218–4226 (2009).
40. Lakshmipathy, U. & Campbell, C. Double strand break rejoining by mammalian mitochondrial extracts. Nucleic Acids Res. 27, 1198–1204 (1999).
41. Srivastava, S. & Moraes, C. T. Double-strand breaks of mouse muscle mtDNA promote large deletions similar to multiple mtDNA deletions in humans. Hum. Mol. Genet. 14, 893–902 (2005).
42. Andreyev, A. Y., Kushnareva, Y. E. & Starkov, A. A. Mitochondrial metabolism of reactive oxygen species. Biochemistry Mosc. 70, 200–214 (2005).
43. Kukat, A. et al. Generation of rho0 cells utilizing a mitochondrially targeted restriction endonuclease and comparative analyses. Nucleic Acids Res. 36, e44 (2008).
44. Chacinska, A., Koehler, C. M., Milenkovic, D., Lithgow, T. & Pfanner, N. Importing mitochondrial proteins: machineries and mechanisms. Cell 138, 628–644 (2009).
45. Moberg, P. et al. NMR solution structure of the mitochondrial F1beta presequence from Nicotiana plumbaginifolia. J. Mol. Biol. 336, 1129–1140 (2004).
46. Saitoh, T. et al. Tom20 recognizes mitochondrial presequences through dynamic equilibrium among multiple bound states. EMBO J. 26, 4777–4787 (2007).
47. Yamano, K. et al. Tom20 and Tom22 share the common signal recognition pathway in mitochondrial protein import. J. Biol. Chem. 283, 3799–3807 (2008).
48. Tamura, Y. et al. Tim23-Tim50 pair coordinates functions of translocators and motor proteins in mitochondrial protein import. J. Cell Biol. 184, 129–141 (2009).
49. Jeandard, D. et al. Import of Non-Coding RNAs into Human Mitochondria: A Critical Review and Emerging Approaches. Cells 8, 286 (2019).
50. Rubio, M. A. T. et al. Mammalian mitochondria have the innate ability to import tRNAs by a mechanism distinct from protein import. Proc. Natl. Acad. Sci. U.S.A. 105, 9186–
9191 (2008).
51. Mercer, T. R. et al. The human mitochondrial transcriptome. Cell 146, 645–658 (2011).
52. Wang, G. et al. PNPASE regulates RNA import into mitochondria. Cell 142, 456–467 (2010).
53. Cameron, T. A., Matz, L. M. & De Lay, N. R. Polynucleotide phosphorylase: Not merely an RNase but a pivotal post-transcriptional regulator. PLoS Genet. 14, e1007654 (2018).
54. Mohanty, B. K. & Kushner, S. R. Polynucleotide phosphorylase functions both as a 3‘ right-arrow 5’ exonuclease and a poly(A) polymerase in Escherichia coli. Proc. Natl.
Acad. Sci. U.S.A. 97, 11966–11971 (2000).
55. Yehudai-Resheff, S., Hirsh, M. & Schuster, G. Polynucleotide phosphorylase functions as both an exonuclease and a poly(A) polymerase in spinach chloroplasts. Mol. Cell. Biol. 21, 5408–5416 (2001).
56. Golzarroshan, B. et al. Crystal structure of dimeric human PNPase reveals why disease-linked mutants suffer from low RNA import and degradation activities. Nucleic Acids Res.
46, 8630–8640 (2018).
57. Fox, T. D. Mitochondrial protein synthesis, import, and assembly. Genetics 192, 1203–
1234 (2012).
58. Becker, T., Böttinger, L. & Pfanner, N. Mitochondrial protein import: from transport pathways to an integrated network. Trends Biochem. Sci. 37, 85–91 (2012).
59. Wada, K.-I., Hosokawa, K., Ito, Y. & Maeda, M. Quantitative control of mitochondria transfer between live single cells using a microfluidic device. Biol Open 6, 1960–1965 (2017).
60. Su, X. & Dowhan, W. Translational regulation of nuclear gene COX4 expression by mitochondrial content of phosphatidylglycerol and cardiolipin in Saccharomyces cerevisiae. Mol. Cell. Biol. 26, 743–753 (2006).
61. Abu-Elheiga, L. et al. The subcellular localization of acetyl-CoA carboxylase 2. Proc.
Natl. Acad. Sci. U.S.A. 97, 1444–1449 (2000).
62. Bravo-Alonso, I. et al. Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease. Hum. Mutat. 38, 678–691 (2017).
63. Bogenhagen, D. F., Rousseau, D. & Burke, S. The layered structure of human mitochondrial DNA nucleoids. J. Biol. Chem. 283, 3665–3675 (2008).
64. Prasannan, P., Pike, S., Peng, K., Shane, B. & Appling, D. R. Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and
immunolocalization in Chinese hamster ovary calls. J. Biol. Chem. 278, 43178–43187 (2003).
65. Walkup, A. S. & Appling, D. R. Enzymatic characterization of human mitochondrial C1-tetrahydrofolate synthase. Arch. Biochem. Biophys. 442, 196–205 (2005).
66. Wang, G., Shimada, E., Koehler, C. M. & Teitell, M. A. PNPASE and RNA trafficking into mitochondria. Biochim. Biophys. Acta 1819, 998–1007 (2012).
67. Wang, G. et al. PNPASE Regulates RNA Import into Mitochondria. Cell 142, 456–467 (2010).
68. Smirnov, A., Entelis, N., Martin, R. P. & Tarassov, I. Biological significance of 5S rRNA import into human mitochondria: role of ribosomal protein MRP-L18. Genes Dev. 25, 1289–1305 (2011).
69. Kolesnikova, O. et al. Selection of RNA aptamers imported into yeast and human mitochondria. RNA 16, 926–941 (2010).
70. Gowher, A., Smirnov, A., Tarassov, I. & Entelis, N. Induced tRNA import into human mitochondria: implication of a host aminoacyl-tRNA-synthetase. PLoS ONE 8, e66228 (2013).
71. Wang, G. et al. Correcting human mitochondrial mutations with targeted RNA import.
Proc. Natl. Acad. Sci. U.S.A. 109, 4840–4845 (2012).
72. Lee, N. S. et al. Functional and intracellular localization properties of U6 promoter-expressed siRNAs, shRNAs, and chimeric VA1 shRNAs in mammalian cells. RNA 14, 1823–1833 (2008).
73. Chen, B. et al. Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System. Cell 155, 1479–1491 (2013).
74. Kim, S. et al. CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 28, 367–373 (2018).